Sign in
4

Changes in Ownership

aTYR PHARMA INC Filed Acc 0000899243-15-001065

Options or other derivatives

  • Director acquired 6,286 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
CLARKE JOHN K Director 2015-07-08 Grant or award · Stock Option (right to buy) +6,286 6,286 D
Loading xslF345X03/doc4.xml…